SWM
ABEO icon

SHP Wealth Management’s Abeona Therapeutics ABEO Stock Holding History

SHP Wealth Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.47K Hold
1,668
– – ﹤0.01% 976
2025
Q4 		$8.79K Buy
+1,668
New +$8.4K ﹤0.01% 865

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SHP Wealth Management's ABEO Position: Q1 2026 in Review

SHP Wealth Management held its Abeona Therapeutics (ABEO) position steady in Q1 2026 at 1,668 shares worth $7.47K. The position accounts for ﹤0.01% of the portfolio, ranked #976.

SHP Wealth Management first reported a position in ABEO in Q4 2025 and has held it in 2 quarters since. The position peaked at $8.79K in Q4 2025. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

  • SHP Wealth Management held 1,668 shares of Abeona Therapeutics worth $7.47K as of Q1 2026.
  • SHP Wealth Management left its Abeona Therapeutics share count unchanged in Q1 2026.
  • Abeona Therapeutics made up ﹤0.01% of SHP Wealth Management's portfolio in Q1 2026, its #976 holding.
  • SHP Wealth Management first reported a position in Abeona Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • SHP Wealth Management's Abeona Therapeutics position peaked at $8.79K in Q4 2025.
  • 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on SHP Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.